Comparative prognostic value of pretreatment inflammation- and nutrition-related biomarkers and development of a HALP-based model for biochemical recurrence after radical prostatectomy
Background Pretreatment inflammatory and nutritional indicators have been associated with the prognosis of prostate cancer, but their comparative predictive value remains unclear. Methods This retrospective study included 355 patients who underwent radical prostatectomy between January 2015 and June 2021. The hemoglobin, albumin, lymphocyte, and platelet (HALP) and seven alternative indices were evaluated using Cox regression, Harrell’s C-index, time-dependent AUC, and Brier scores. Restricted cubic splines were used to assess the nonlinear association between HALP and biochemical recurrence-free survival (BCRFS). A model incorporating the positive biopsy core ratio, pathological N stage, and spline-modeled HALP was compared with the Cancer of the Prostate Risk Assessment (CAPRA) score and CAPRA plus HALP. Internal validation was performed using 1,000 bootstrap resamples. Results During follow-up, 63 patients experienced biochemical recurrence. HALP showed the highest overall discrimination among the evaluated indices. Restricted cubic spline analysis demonstrated a significant nonlinear association between HALP and BCRFS (overall p < 0.001; nonlinear p = 0.007), with recurrence risk decreasing sharply at lower HALP levels and then approaching a plateau. Nonlinear modeling improved model fit compared with the linear specification (likelihood-ratio p = 0.007; ΔAIC = −5.53). Bootstrap-corrected C-indices were 0.641 for CAPRA, 0.667 for CAPRA plus HALP, and 0.682 for the proposed model. The proposed model showed satisfactory calibration, promising apparent net benefit, and significant risk stratification (log-rank p < 0.0001). Conclusion HALP was nonlinearly associated with BCRFS after radical prostatectomy. A preliminary internally validated model combining clinicopathological factors and spline-modeled HALP showed better prognostic performance than CAPRA alone, although external validation is required.
Authors
- Jiangbin Yang
- 闻尧安
- Shuyuan Zhan
- Y.-F. Su
- Bufang Xiong
- Jing Lin
- Shaoxing Zhu
- Song Zheng
- Shuai Lin
Institutions
- Jiangnan University (CN)
- Longyan University (CN)
- Wuxi No.2 People's Hospital (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fnut.2026.1925099
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Fujian Medical University